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Mitochondrial disorders are rare metabolic diseases. They often present during neonatal period but with 
nonspecific clinical features such as feeding difficulties, failure to thrive, and seizures. Mitochondrial 
defects have also known to be associated with neurological disorders, as well as cancers. We report 
the first case of neonatal mitochondrial respiratory chain defect with sarcoma botryoides confirmed by 
pathologic diagnosis, suggesting another possible link between mitochondrial dysfunction and cancer.
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Introduction
Mitochondrial disorders are uncommon energy 
metabolic diseases1-4). Since mitochondrial dys-
function induces lower energy production of cel-
lular bases in affected organs, a great variety of 
symptomatology and progressive course are re-
sulted in most cases. Furthermore, neonatal pre-
sentation is relatively common because of the high 
energy requirements of the growing newborn. 
Clinical unspecific features such as hypotonia, 
feeding difficulties, failure to thrive, and seizures 
are seen frequently as early-onset manifestation5). 
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A rapid and fatal course is generally expected in 
neonatal patients, because the age of onset is the 
strongest predictor of mortality in mitochondrial 
disorders6, 7). 
Rhabdomyosarcoma is the most common soft 
tissue sarcoma of childhood, categorized as a cli-
nically and biologically heterogeneous disease8). 
Sarcoma botryoides is a form of embryonal rhab-
domyosarcoma that tends to be less invasive than 
other forms and known to show favorable prog-
nosis8, 9). 
There has been no case reported yet about 
mitochondrial respiratory chain enzyme complex 
(MRC) defect with rhabdomyosarcoma. To our 
knowledge, this is the first case of mitochondrial 
cytopathy concurrent with sarcoma botryoides 
diagnosed in pediatric population.
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Fig. 1. Axial T2-weighted MRI showed nonspecific 
finding considering the patient’s age.
Fig. 2. Proton MR spectroscopy showed small but definite lactate peak(arrow) at right 
frontal lobe and right basal ganglia (Cho: choline; Cr: creatine; NAA: N-acetyl-
aspartate; Lac; latate).
Case Report
A 1-month-old female neonate was admitted 
to our hospital with failure to thrive. She had nor-
mal birth history, but feeding difficulty and seizure 
like movement were noticed after then. She also 
gradually developed hypotonicity. Her parents 
were not consanguineous, and no family member 
including two elder brothers had shown abnormal 
neurological symptoms. On physical examination, 
she showed chronic ill looking appearance and had 
a head circumference 40 cm (50-75 percentile) 
with no dysmorphic morphology. No organomegaly 
was observed. During neurological examination, 
hypotonia and not increased deep tendon reflexes 
were seen. Asymptomatic premature atrial con-
traction, premature ventricular contraction, and 
atrial tachycardia without cardiac murmur were 
observed in electrocardiogram. But no cardiac 
anomaly was observed in echocardiography. Lac-
tate level was elevated in blood and cerebrospinal 
fluid. Brain magnetic resonance imaging demon-
strated no abnormal findings while proton magnetic 
resonance spectroscopy revealed small but definite 
lactate peak at right frontal lobe and right basal 
ganglia (Fig. 1, 2). Elevated alanine and lysine 
were observed on plasma amino acid assay, and 
nonspecific mild organic aciduria was noted on 
urine organic acid assay. Muscle biopsy was per-
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Fig. 4. Pelvic MRI showed lobulated heterogenous mass
in perineum (arrow). It contained both solid and
cystic features. 
Fig. 5. Characteristic grape-like polypoid mass of sar-
coma botryoides measuring 5.2×11.5 cm was 
observed.
Fig. 3. Electron microscopy showed multiple megaconia 
between subsarcolemmal area and intermyofibrillar
area.
Fig. 6. Cambium layer, a subepithelial condensation of 
tumor cells separated from an intact surface 
epithelium zone, was seen under light microscopy
(H&E staining, ×160).
formed, and abnormal features of multiple mega-
conia were identified under electron microscopy 
(Fig. 3). On biochemical enzyme assay for mito-
chondrial respiratory chain using spectrophoto-
metric method in muscle tissue, MRC II defect 
was confirmed finally defined as lower than 10% 
of that in controls10). We started cocktail therapy 
including coenzyme Q10, L-carnitine and multi-
vitamin after diagnosis of mitochondrial cytopathy. 
Her development was improved after mitochon-
drial cocktail therapy. A vaginal mass was detected 
at the age of 6 months. The mass had charac-
teristic polypoid appearance resembling a bunch 
of grapes. It was gradually increased in size of an 
adult fist. Pelvic MRI showed lobulated hetero-
genous mass in perineum and it contained both 
solid and cystic features (Fig. 4). Excision was 
made. The specimen was of a typical polypoid 
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mass measuring 5.2×11.5 cm (Fig. 5). Pathologic 
diagnosis was made botryoid rhabdomyosarcoma 
(Fig. 6). She is on chemotherapy for management 
of rhabdomyosarcoma now. 
Discussion
Mitochondrial defects have been associated with 
neurological disorders, as well as cancers11). Some 
research showed an ‘injury’ to the respiratory 
chains such as mtDNA mutation, deletion or de-
pletion can be a key event in carcinogenesis12, 13). 
In addition, several reports showed that mutations 
of mtDNA have been identified in various types 
of cancer including breast cancer, colon carcinoma, 
prostate cancer, pancreatic cancer, etc14). Also in 
some reports, decreased mitochondrial respiratory 
function was observed in accordance with in-
creased invasiveness of cancer15). 
Summary
We report the 1st case of neonatal MRC defect 
with sarcoma botryoides confirmed by pathologic 
diagnosis suggesting a possible link between mito-
chondrial respiratory chain defect and rhabdomyo-
sarcoma. Though there have been a few reports 
about mitochondrial dysfunction and certain types 
of cancer, there have not been attempts to study 
the relationship between MRC defect and rhabdo-
myosarcoma. So, further studies are needed to 
establish the relationship. 
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